Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Receivables - Net (2016 - 2025)

Fortress Biotech has reported Receivables - Net over the past 11 years, most recently at $29.8 million for Q4 2025.

  • Quarterly results put Receivables - Net at $29.8 million for Q4 2025, up 191.11% from a year ago — trailing twelve months through Dec 2025 was $29.8 million (up 191.11% YoY), and the annual figure for FY2025 was $29.8 million, up 191.11%.
  • Receivables - Net for Q4 2025 was $29.8 million at Fortress Biotech, up from $18.0 million in the prior quarter.
  • Over the last five years, Receivables - Net for FBIO hit a ceiling of $31.7 million in Q3 2021 and a floor of $8.0 million in Q3 2023.
  • Median Receivables - Net over the past 5 years was $19.4 million (2021), compared with a mean of $20.6 million.
  • Biggest five-year swings in Receivables - Net: surged 259.98% in 2021 and later plummeted 72.0% in 2023.
  • Fortress Biotech's Receivables - Net stood at $23.1 million in 2021, then increased by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then plummeted by 32.79% to $10.2 million in 2024, then skyrocketed by 191.11% to $29.8 million in 2025.
  • The last three reported values for Receivables - Net were $29.8 million (Q4 2025), $18.0 million (Q3 2025), and $15.6 million (Q2 2025) per Business Quant data.